BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kang L, Rosenkrans ZT, Cai W. 64Cu-Labeled Aptamers for Tumor-Targeted Radionuclide Delivery. Methods Mol Biol 2019;1974:223-31. [PMID: 31099007 DOI: 10.1007/978-1-4939-9220-1_17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 García Melián MF, Moreno M, Cerecetto H, Calzada V. Aptamer-Based Immunotheranostic Strategies. Cancer Biother Radiopharm 2023. [PMID: 36603108 DOI: 10.1089/cbr.2022.0064] [Reference Citation Analysis]
2 Swaminathan G, Shigna A, Kumar A, Byroju VV, Durgempudi VR, Dinesh Kumar L. RNA Interference and Nanotechnology: A Promising Alliance for Next Generation Cancer Therapeutics. Front Nanotechnol 2021;3:694838. [DOI: 10.3389/fnano.2021.694838] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
3 Sicco E, Baez J, Ibarra M, Fernández M, Cabral P, Moreno M, Cerecetto H, Calzada V. Sgc8-c Aptamer as a Potential Theranostic Agent for Hemato-Oncological Malignancies. Cancer Biother Radiopharm 2020;35:262-70. [PMID: 32407201 DOI: 10.1089/cbr.2019.3402] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]